
July 26–30, Anaheim Convention Center
Diagnostics is moving faster, reaching further, and growing more complex by the day. With growth comes pressure on labs to maintain standards, sustain oversight, and ensure consistent clinical decision‑making as care expands beyond the core lab.
The future of diagnostics won’t be defined by stretching today’s model to meet tomorrow’s demands. It requires partners who offer fresh thinking and forward focused technologies, so labs can confidently grow their business and expand access to care.

Location: Anaheim Convention Center, Anaheim, California, USA (Map, Floor plan)

Clinical excellence starts with more forward-looking insight. With advanced biomarkers and expanding prognostic capabilities, laboratories can help clinicians detect risk earlier, better understand disease progression, and guide care with greater confidence across complex conditions.

Growing complexity demands an integrated, connected approach. Streamlined workflows and connected systems reduce manual steps and variability—helping labs scale volume and complexity with consistency, so teams can focus on higher-value work.

As care extends beyond the central lab, consistent, high-quality diagnostics must extend with it. Flexible sampling and connected informatics help bring testing closer to patients while supporting reliable, standardized results across settings—so labs can support decentralized care and expand reach.
At ADLM 2026, our educational workshops highlight how laboratories are advancing clinical impact through innovative diagnostics, intelligent automation, and clinical collaboration—spanning liver disease, allergy and immunology, neurology, and AI-enabled systems and robotics.
Join us Tuesday, July 28, and Wednesday, July 29, in Theater 1 for four engaging workshops featuring real‑world insights, expert perspectives, and practical takeaways you can apply in today’s laboratory environment.
*Lunch will be provided for attendees in all four workshops.

This informative session examines the role of the Enhanced Liver Fibrosis (ELF®) Test in real‑world practice through a multidisciplinary lens. Each speaker will anchor their discussion on the importance of early risk assessment for disease progression in patients with MASH and how non-invasive tests can support earlier risk assessment and clinical action.
Presenters:
Amreen M. Dinani, MD, MSc, FRCPC, ABOM
Associate Professor of Medicine
Duke University School of Medicine, USA
Nikola A. Baumann, PhD, DABCC
Vice Chair of Quality, Department of Laboratory Medicine, and Pathology
Director of Central Clinical Laboratory and CLIA Lab Director
Mayo Clinic Laboratories, USA
Moderator:
Leontine Narcisse-Ogera, MD, PhD
SVP, Head of Medical and Scientific Strategy, Medical Communications, eNova
*Lunch will be provided for attendees.

This interactive, debate-driven workshop uses familiar immunoassay and allergy testing scenarios to explore everyday lab trade-offs, highlighting practical automation and clinical decision considerations to better align operations with patient-centered care.
Presenters:
Sridevi Devaraj, PhD, DABCC, FAACC, FRSC, CCRP
Director of Laboratories
Texas Children’s Microbiome Centre, USA
Guilherme Birchal Collares, MD
Chief Operating Officer
Instituto Hermes Pardini S.A., Brazil
*Lunch will be provided for attendees.

Join two global leaders—Professor Henrik Zetterberg, a pioneer in neurology biomarkers, and Dr. Bill Clarke, a leading diagnostics expert—for a high‑impact discussion on progressing neurology biomarkers from discovery to potential future clinical use.
Presenters:
Henrik Zetterberg, MD, PhD
Professor of Neurochemistry
University of Gothenburg, Sweden
University College London, UK
University of Wisconsin-Madison, USA
Bill Clarke, PhD
Professor of Pathology
Johns Hopkins University, USA
This educational activity will be submitted to ADLM for approval
of up to 1.0 ACCENT credit.
*Lunch will be provided for attendees.

Discover how automation, robotics, and AI are shaping the future laboratory. Learn how intelligent, autonomous systems enable continuous operations, reduce errors, and transform labs into proactive diagnostic intelligence hubs that enable more precise interventions and enhance patient outcomes.
Presenters:
Matthew Shashack, PhD
Director of Clinical Chemistry and Toxicology
OU Health, USA
Gaby Marquardt, PhD
Global Head of Clinical and Technology Innovation
Siemens Healthineers
Moderator and Presenter:
Paavana Sainath, M.S., MBA
SVP & Head of R&D Engineering – Laboratory Solutions
Siemens Healthineers
*Lunch will be provided for attendees.

Where Clinical Evidence Meets Innovation
Posters will be on display from 9:30 a.m. until 5:00 p.m. (PDT) on the expo show floor.
Posters will be presented in person from 1:30 p.m. until 2:30 p.m. (PDT).
ePosters will be available to attendees on ADLM's ePoster platform from July 28 to August 31.
CATEGORY | POSTER TITLE | AUTHORS (presenter's name first) |
Clinical Chemistry | Analytical Performance Evaluation of the Diazo Total Bilirubin Assay on the Atellica CH Analyzer for Use in Neonates | Mark Borgman, Dejan Blagovcanin, Zach Eischeid, Anne Sinopoli, Jennifer Cheek, Nazira Ozgen, Jennifer Snyder. |
Hematology | Comprehensive Overview of Preliminary Interference Data for a New D-Dimer Assay | Johanna Droese, Sabine Pilgrim, Matthias Wilkens. |
Infectious Disease | Performance Evaluation of Atellica IM Infectious Disease Assays with Dried Blood Spot Sample | Sai Patibandla, Krishna Singh, Katie Ann Paden. |
Microsampling | Comparison of Capillary Blood to Venous Blood for Use with the Vitamin D Total II Assay on the Atellica IM Analyzer | Agostino Palladino, Brandon Czap, Nancy Camosino, Christopher DiPasquale, Eric G. Olson, Roy Barr, Hattie McKenzie, James W. Jacobson. |
Microsampling | Comparison of Test Results for Several Analytes Using Capillary Blood Versus Venous Blood on the Atellica CH and Atellica IM Analyzers | James Freeman, Jennifer Cheek, Sangita Singh, Christopher DiPasquale, Eric G. Olson, Roy Bar, Hattie McKenzie, James W. Jacobson. |
Microsampling | Quantitative Analysis of Creatinine and HbA1c from Dried Microsamples as a Patient-centered Approach for Value-Based Care Programs | Ramona Seliger, Jens-Peter Brock, Michelle Wittmann, Mathias Karlsson, Johan Olausson, Mikael Ström. |
Point of Care Testing | Comparative Analytical Performance of the epoc Blood Analyzer: a Multi-Platform Evaluation of Blood Gas, Electrolyte, and Metabolite Assays | Amy Ng, Patricia Harding-Lepage, Tim Hobbs, JoDell Wilson, Viral Panchal, and Jeff Franklin. |
Reproductive Endocrinology | Short-term Prediction of Severe Preeclampsia Among Women with Hypertensive Disorders of Pregnancy | Sara Love, Agostino Palladino, Andrea Wright, Katie Freeman, Sara Kastrup Shah, JoDell Wilson, Sascha Lange, and Maria Pagano. |
Sepsis | Comprehensive Performance Evaluation of a Rapid, Universal, Sepsis Diagnostic Workflow That Identifies Pathogens and Characterizes Their Antimicrobial Resistance | Ramya VM, Thomas A Hall, Divya S Khandige, Ishita Chakraborty, Lisa Risen, Christine Marzan, Michael Mosel, Jim Hannis, Hila Roshanravan, Robert A. Bonomo, and Megan Carpenter. |
Sepsis | Development of Pre-analytics for a Rapid, Integrated Sepsis Diagnostic Workflow Combining Pathogen Detection with Host Immune Response Profiling | Divya Sharma Khandige, Josh Chenoweth, Ramya VM, Deeksha Hebbar, Chad Porter, Danielle Clark, Thomas A Hall, Lisa Risen, Christine Marzan, Michael Mosel, James Hannis, Hila Roshanravan, and Megan Carpenter. |
Therapeutic Drug Monitoring | Analytical Precision and On-board Stability Evaluation of the EMIT Methotrexate and Amikacin and EMIT 2000 Vancomycin and Digoxin Assays on the Atellica DT 250 Analyzer | Jessica Daughtry, Kenisha Griffin, Jerry Glover, Nicholas Johnson, Benjamin Israel |

Take a pause from the show floor and experience LabPawPalooza—a moment to recharge, smile, and connect. Visit the Puppy Zone in Booth #5542 and spend some time with a few four‑legged friends during ADLM.
After visiting, stop by Booth #3201 to see how forward-thinking diagnostics can reach further across the lab.